Treatment Options for Patients with Superficial Bladder Cancer Failing Prior BCG

Michael O'Donnell, MD

Associate Professor of Urology
Director of Urologic Oncology
University of Iowa Hospitals and Clinics
September, 2002

Presented at Division of Urology Grand Rounds,
Vancouver General Hospital, Vancouver, British Columbia
49 minutes duration.

Objectives:

• Review the natural history and current BCG treatment of superficial bladder cancer
• Focus on treatment options when BCG treatment fails, including ancillary chemotherapy and combination immunotherapy with Interferon-alpha
• Present current treatment algorithms for treatment of superficial bladder cancer

• This event is eligible for Section 2 CME credit as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and may also be incorporated into a personal learning project (PLP) under Section 4 (Structured Learning Projects).
• This event is eligible for one hour of Section 2 CME credit